Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations
Thématique(s) / pathologie(s)
- Maladie de Parkinson
Objectifs
Plus d'informations disponibles sur : https://clinicaltrials.gov/ct2/show/NCT02006121?term=toledo&cond=parkinson&cntry=FR&draw=2&rank=1
Promoteur
Britannia Pharmaceuticals Ltd.
Publication(s) scientifique(s)
-
Katzenschlager R et al. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2018 Sep;17(9):749-759.
Statut
Résultats publiés